Antibodies to polioviruses in an Israeli population and overseas volunteers.
A seroepidemiological survey of prevalence of antibodies to poliovirus types 1-3 was carried out in 1,800 residents of 30 agricultural settlements (kibbutzim) in Israel during 1980 and 1981. The survey showed that in 1980 84%, 90%, and 79% of the kibbutz residents exhibited antibodies to poliovirus types 1-3, respectively. In 1981 the figures were 81%, 91%, and 73%. Significantly lower levels of antibodies for poliovirus type 3 in 1980/1981, and for poliovirus type 1 in 1981, were noticed in the age group 6-17 years compared with the age group of greater than 18 years. Infants and young children of the kibbutzim received the Salk polio vaccine during 1957-1961 and the Sabin oral polio vaccine since 1961. Among overseas volunteers from Western countries who came during 1980 and 1981 to work in the kibbutzim for a limited period of time, 88% exhibited antibodies to poliovirus type 1, 94% to poliovirus type 2, and 75% to poliovirus type 3. No significant differences in the level of antibodies were detected between males and females or between residents in those kibbutzim using or not using wastewater for irrigation.
Margalith
M
M
Division of Environmental Sciences, Graduate School of Applied Science and Technology Hebrew University of Jerusalem, Israel.
Morag
A
A
Fattal
B
B
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000914:Antibodies, Viral / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007557:Israel / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011051:Poliomyelitis / Q000453:epidemiology / Q000276:immunology*; D017955:Poliovirus / Q000276:immunology*; D015995:Prevalence; D012737:Sex Factors
D000914:Antibodies, Viral